Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023
| Autor(a) principal: | |
|---|---|
| Data de Publicação: | 2024 |
| Outros Autores: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Tipo de documento: | Artigo |
| Idioma: | eng |
| Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| Texto Completo: | http://hdl.handle.net/10400.18/8934 |
Resumo: | Members of the European Hospital Vaccine Effectiveness Group: Portugal: Ana Paula Rodrigues, Débora Pereira, Susana Costa Maia e Silva, Paula Pinto, Cristina Bárbara, António Pais de Lacerda, Raquel Guiomar and Camila Henriques. |
| id |
RCAP_20f5ec062fa1c4ca4ea52365b0046956 |
|---|---|
| oai_identifier_str |
oai:repositorio.insa.pt:10400.18/8934 |
| network_acronym_str |
RCAP |
| network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository_id_str |
7160 |
| spelling |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023COVID-19COVID-19 Bivalent VaccinesHospitalisationSARIXBBVEBIS-LOT 1SARS-CoV-2Vaccine EffectivenessEuropeVacinaEfetividadeObservação e vigilânciaInfecções RespiratóriasCuidados de SaúdeMembers of the European Hospital Vaccine Effectiveness Group: Portugal: Ana Paula Rodrigues, Débora Pereira, Susana Costa Maia e Silva, Paula Pinto, Cristina Bárbara, António Pais de Lacerda, Raquel Guiomar and Camila Henriques.The European Medicines Agency (EMA) authorised four adapted bivalent mRNA COVID-19 vaccines for use against COVID-19 in September/October 2022: Comirnaty (BNT162b2; Pfizer-BioNTech) and Spikevax (mRNA-1273; Moderna) Original/Omicron BA.1 and Original/Omicron BA.4–5 [1]. During autumn 2022, all European Union/European Economic Area (EU/EEA) countries had vaccination campaigns in place to administer a booster dose, with several countries using the adapted bivalent vaccines [2]. The Omicron-descendent XBB lineage and XBB.1.5 sub-lineage became variants of interest in March 2023 [3]. We estimated the effectiveness of the COVID-19 bivalent vaccines against hospitalisation with PCR-confirmed SARS-CoV-2 infection among patients aged ≥ 60 years with severe acute respiratory infection (SARI) during the XBB lineage-predominant period.The ‘Vaccine Effectiveness, Burden and Impact Studies studies’ (VEBIS) is a project of the European Centre for Disease Prevention and Control (ECDC) run under the framework con tract No. ECDC/2021/016.European Centre for Disease Prevention and ControlRepositório Científico do Instituto Nacional de SaúdeAntunes, LilianaMazagatos, ClaraMartínez-Baz, IvánGómez, VerónicaBorg, Maria-LouisePetrović, GorankaDuffy, RóisínDufrasne, François EDürrwald, RalfLazar, MihaelaJancoriene, LigitaOroszi, BeatrixHusa, PetrHoward, JenniferMelo, ArysePozo, FranciscoPérez-Gimeno, GloriaCastilla, JesúsMachado, AusendaDžiugytė, AušraKarabuva, SvjetlanaFitzgerald, MargaretFierens, SébastienTolksdorf, KristinPopovici, Silvia-OdetteMickienė, AuksėTúri, GergőSoučková, LenkaNicolay, NathalieRose, Angela MCon behalf of the European Hospital Vaccine Effectiveness Group2024-01-22T10:59:07Z2024-01-182024-01-18T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.18/8934engEuro Surveill. 2024 Jan;29(3):2300708. doi: 10.2807/1560-7917.ES.2024.29.3.23007081025-496X10.2807/1560-7917.ES.2024.29.3.2300708info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-01-27T01:32:20Zoai:repositorio.insa.pt:10400.18/8934Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T01:58:00.792190Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
| dc.title.none.fl_str_mv |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| title |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| spellingShingle |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 Antunes, Liliana COVID-19 COVID-19 Bivalent Vaccines Hospitalisation SARI XBB VEBIS-LOT 1 SARS-CoV-2 Vaccine Effectiveness Europe Vacina Efetividade Observação e vigilância Infecções Respiratórias Cuidados de Saúde |
| title_short |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| title_full |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| title_fullStr |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| title_full_unstemmed |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| title_sort |
Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 |
| author |
Antunes, Liliana |
| author_facet |
Antunes, Liliana Mazagatos, Clara Martínez-Baz, Iván Gómez, Verónica Borg, Maria-Louise Petrović, Goranka Duffy, Róisín Dufrasne, François E Dürrwald, Ralf Lazar, Mihaela Jancoriene, Ligita Oroszi, Beatrix Husa, Petr Howard, Jennifer Melo, Aryse Pozo, Francisco Pérez-Gimeno, Gloria Castilla, Jesús Machado, Ausenda Džiugytė, Aušra Karabuva, Svjetlana Fitzgerald, Margaret Fierens, Sébastien Tolksdorf, Kristin Popovici, Silvia-Odette Mickienė, Auksė Túri, Gergő Součková, Lenka Nicolay, Nathalie Rose, Angela MC on behalf of the European Hospital Vaccine Effectiveness Group |
| author_role |
author |
| author2 |
Mazagatos, Clara Martínez-Baz, Iván Gómez, Verónica Borg, Maria-Louise Petrović, Goranka Duffy, Róisín Dufrasne, François E Dürrwald, Ralf Lazar, Mihaela Jancoriene, Ligita Oroszi, Beatrix Husa, Petr Howard, Jennifer Melo, Aryse Pozo, Francisco Pérez-Gimeno, Gloria Castilla, Jesús Machado, Ausenda Džiugytė, Aušra Karabuva, Svjetlana Fitzgerald, Margaret Fierens, Sébastien Tolksdorf, Kristin Popovici, Silvia-Odette Mickienė, Auksė Túri, Gergő Součková, Lenka Nicolay, Nathalie Rose, Angela MC on behalf of the European Hospital Vaccine Effectiveness Group |
| author2_role |
author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author |
| dc.contributor.none.fl_str_mv |
Repositório Científico do Instituto Nacional de Saúde |
| dc.contributor.author.fl_str_mv |
Antunes, Liliana Mazagatos, Clara Martínez-Baz, Iván Gómez, Verónica Borg, Maria-Louise Petrović, Goranka Duffy, Róisín Dufrasne, François E Dürrwald, Ralf Lazar, Mihaela Jancoriene, Ligita Oroszi, Beatrix Husa, Petr Howard, Jennifer Melo, Aryse Pozo, Francisco Pérez-Gimeno, Gloria Castilla, Jesús Machado, Ausenda Džiugytė, Aušra Karabuva, Svjetlana Fitzgerald, Margaret Fierens, Sébastien Tolksdorf, Kristin Popovici, Silvia-Odette Mickienė, Auksė Túri, Gergő Součková, Lenka Nicolay, Nathalie Rose, Angela MC on behalf of the European Hospital Vaccine Effectiveness Group |
| dc.subject.por.fl_str_mv |
COVID-19 COVID-19 Bivalent Vaccines Hospitalisation SARI XBB VEBIS-LOT 1 SARS-CoV-2 Vaccine Effectiveness Europe Vacina Efetividade Observação e vigilância Infecções Respiratórias Cuidados de Saúde |
| topic |
COVID-19 COVID-19 Bivalent Vaccines Hospitalisation SARI XBB VEBIS-LOT 1 SARS-CoV-2 Vaccine Effectiveness Europe Vacina Efetividade Observação e vigilância Infecções Respiratórias Cuidados de Saúde |
| description |
Members of the European Hospital Vaccine Effectiveness Group: Portugal: Ana Paula Rodrigues, Débora Pereira, Susana Costa Maia e Silva, Paula Pinto, Cristina Bárbara, António Pais de Lacerda, Raquel Guiomar and Camila Henriques. |
| publishDate |
2024 |
| dc.date.none.fl_str_mv |
2024-01-22T10:59:07Z 2024-01-18 2024-01-18T00:00:00Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10400.18/8934 |
| url |
http://hdl.handle.net/10400.18/8934 |
| dc.language.iso.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
Euro Surveill. 2024 Jan;29(3):2300708. doi: 10.2807/1560-7917.ES.2024.29.3.2300708 1025-496X 10.2807/1560-7917.ES.2024.29.3.2300708 |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.format.none.fl_str_mv |
application/pdf |
| dc.publisher.none.fl_str_mv |
European Centre for Disease Prevention and Control |
| publisher.none.fl_str_mv |
European Centre for Disease Prevention and Control |
| dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
| instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| instacron_str |
RCAAP |
| institution |
RCAAP |
| reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
| repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
| repository.mail.fl_str_mv |
|
| _version_ |
1799137065698328576 |